1Shah P K,Falk g,Badimon J J,et al.Human monocytederived macrophages induce collagen breakdown in fibrous caps of atherosc1erotic plaque:potential role of matri x degrading meta11oproteinases and implications for plaque rupture[J].Circulation,1995,92:1565.
2Koenig W,Sund M,Frhlich M,et al.C-reactive protein,a sensitive marker of inflammation,predicts future risk coronary heart disease in inltially health middle-aged men:results from the MONICA(Monitoring Trends and Determinants in Cardiovascular Disease)Augsburg Cohort Study,1984 to 1992[J].Circulation,1999,99:237.
3Brown DL,Hibbs MS,Kearney M,et al.Identification of 92-KD gelatinase inhuman coronary atherosclerotic lesions:Association of active enzyme synthesiswith unstable angina[J].Circulation,1995,91(8):2125.
4Schwartz GG,Olsson,Ezekowitz MD,et al.Effect of atorvastatin on early recurrent ischemia events in acute coronary Syndromes[J].JAMA,2001,285:1711.
5Pearson TA,Mensah GA,Alexander RW,et al.Markeers of inflammation and cardiovascular disease,application to clinical and public health practice:a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association[J].Circulation,2003,107:499.
8Liu P, Sun M, Sader S. Matrix metalloproteinases in cardiovascular disease [ J ]. Can J Cardiol,2006,22 (Suppl B) :25 B-30B.
9Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease [J]. Biochem Pharmacol,2008,75 (2) :346-359.
10Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs) :an ancient family with structural and functional diversity [J]. Biochim Biophys Acta,2010,1803( 1 ) :55-71.
